As Cerulean continues to grow and advance our technologies and programs, we are committed to clear and consistent communication to our external audiences. Here we feature current and historic information concerning our technology, our pipeline and our corporate goals and achievements. Please check in often for the most recent press releases and news coverage.

In The News

Jan. 2012 - CNBC

Oliver Fetzer interviewed on CNBC Power Lunch segment: VC Backs Life Sciences

Nov. - Dec. 2011 - PharmaVOICE

- "C-Suite: Executive Insights"
- "Building a Culture of Innovation"
- "Ensuring Pipeline Growth"

Nov. 2011 - CBS Evening News

Mark Davis, Ph.D., inventor of Cerulean Pharma's lead clinical candidate, CRLX101, featured on CBS Evening News November 10, 2011

Sept. 2011 - Cancer Discovery

Nanoparticle Theories Slowly Turn into Practice (Subscription Required)

Sept. 2011 - Cancer Discovery

Nanoparticle Theories Slowly Turn into Practice

July / Aug. 2011 - PharmaVoice

Cerulean Appoints Medical Chief

July 27 2011 - Xconomy

Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi

July 18, 2011 - BioCentury

Cerulean began an open-label, Russian and Ukrainian Phase II trial to compare CRLX101

June 13, 2011 - BioWorld Today

FDA Takes Small Step Towards Regulating Nanotechnology

May 23, 2011 - BioCentury

Edward Garmey hired as CMO and SVP

April 25, 2011 - BioCentury

BioBusiness for the week ended April 22

March 13, 2011 - Boston Globe

Everything you need to know about biotech — on five floors in Cambridge

Jan. 24, 2011 - Xconomy Boston

Top 10 List of Boston-Area VC Deals for Q4 2010